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Abstract
Introduction Protonmagneticresonancespectroscopy(MRS)
and diffusion tensor imaging (DTI) yield different parameters
for characterizing the evolution of a demyelinating white
matter disease. The purpose was to elucidate biochemical and
microstructural changes in Balo’s concentric sclerosis lesions
and to correlate the findings with the clinical course.
Methods Localized short-echo time MRS and DTI were
performed over 6 years in a left occipital lesion of a female
patient (age at onset 13.8 years) with Balo’s concentric
sclerosis. A right homonym hemianopsia persisted.
Results Metabolite patterns were in line with initial active
demyelination followed by gliosis and partial recovery of
neuroaxonal metabolites. Fractional anisotropy and mean
diffusivity of tissue water remained severely altered. Fiber
tracking confirmed a disruption in the geniculo-calcarine
tract as well as involvement of the corpus callosum.
Conclusion MRSandDTIdepictcomplementaryparameters,
but DTI seems to correlate better with clinical symptoms.
Keywords Balo’sconcentricsclerosis.Childhood.
Magneticresonancespectroscopy.
Diffusiontensorimaging.tNAArecovery
Introduction
Balo’s concentric sclerosis (BC) is a demyelinating disorder
and considered a rare variant of multiple sclerosis (MS) [1].
Pathognomonic MRI features include large concentric ring-
like or whorled-appearing lesions in white matter (WM)
with alternating hyper- and hypointense bands on T2-
weighted images with, if active, multiple consecutively
enhancing and non-enhancing layers on contrast-enhanced
T1-weighted MRI [2]. Neuropathologically, the lesion is
characterized by alternating circular lamellae of well
preserved and demyelinated WM [3]. Several hypotheses
have been brought forward to explain this conspicuous
pattern. The myelinated bands have either been considered
areas of remyelination that develop between successive
episodes of active demyelination [4] or early stages of
demyelination [5]. Moore et al. [6] postulated a lesion to
start as a confluent area of demyelination which spreads
centrifugally, becomes downregulated and blazes up again
at the periphery. Immunopathological studies suggested a
resemblance to hypoxic tissue injuries as Stadelmann et al.
[7] reported signs of neuroprotection at the edge of actively
demyelinating bands possibly including oligodendrocytes
that are resistant to further damage hence leading to the
concentric preservation.
So far, proton magnetic resonance spectroscopy (MRS)
studies of BC have only been performed in adult patients
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Göttingen, Germany[2, 8, 9], including follow-up measurements over up to
23 months [10-13]. More recently, diffusion tensor imaging
(DTI) has been applied [11, 13–15]. However the MRI
findings of a 4-year-old boy by Murakami et al. [16] seem
to be the only study from the pediatric patient population.
Here, we report a combined follow-up MRS and DTI study
over almost 6 years of a child diagnosed with BC. The
study was carried out to better elucidate underlying
biochemical and microstructural alterations depicted by
the different MR-methods and their correlations with the
evolution of clinical symptoms.
Materials and methods
Clinical history
The previously healthy 13.8-year-old girl was admitted at
another hospital with an acute right homonym hemianopsia,
increasing sleepiness, anomia, and perturbed consciousness
following a febrile upper respiratory tract infection. Despite
several therapeutic trials (dexamethason, aciclovir, rocephin
intravenous and predison per os) the clinical condition
worsened. MRI examinations within the first month after
onset of symptoms showed a small lesion in left frontal
WM with contrast enhancement, another small lesion
within right frontal WM, and a most prominent lesion with
widespread edema in the left hemisphere involving parietal,
temporal, and occipital lobe and demonstrating a temporary
cockade-like contrast enhancement.
On admission to our department 1 month later, clinical
examination revealed dysarthria, akalulia, sensoric aphasia,
and alexia. Further consecutive MRI examinations showed
a regression of the pronounced left parieto-occipital (LPO)
WM lesion as depicted in Fig. 1a,b (2 months after onset of
symptoms) versus Fig. 1c,d (one month later). Cerebro-
spinal fluid investigations revealed a pleozytosis of
30 cells/μl, oligoclonal IgG, and DNA of human herpes
Fig. 1 MRI of a 13-year-old
child with Balo’s concentric
sclerosis at (a,b) 2 months and
(c,d) 3 months after onset of
symptoms. a Axial FLAIR image
demonstrating the concentric pat-
tern of the two left-hemispheric
lesions and b T1-weighted image
depicting the VOI selected for
proton MRS. c Axial FLAIR and
d T1-weighted image showing
regression of the left parieto-
occipital lesion
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with foscarnet. In a second spinal tap and serum sample after
4 weeks, no HHV-6 DNAwas detectable anymore [17]. Over
the following 3 months, all symptoms improved significantly
except for the hemianopsia which persists up to this day.
Seven months later, a first relapse occurred with a
complex-partial seizure, abulia, and hypokinesia with
subsequent remittance. MRI of the brain showed a new
contrast-enhancing, concentric lesion in the right frontal
premotor region. The known LPO WM lesion appeared
smaller.Foscarnet and methylprednisolonewereadministered
intravenously. A maintenance therapy with immunoglobulin
(2 g/kg intravenous) was added for 8 months.
Thesecondrelapseoccurred3.4yearsaftertheonsetwitha
left hemiparesis, which was again treated with intravenous
methylprednisolone. A new concentric lesion was identified
within the right suprathalamic region. On T1-weighted
images, the LPO WM lesion had transformed to a hypo-
intense, chronic lesion. The remission has so far been
incomplete leaving the patient with a left spastic hemiparesis.
She now receives an immunomodulatory therapy with α-
interferon. Follow-up MRI did not show any new lesion but a
considerable atrophy in the LPO WM region.
Proton MR spectroscopy
AtotalofsevenlocalizedprotonMRSstudieswereperformed
1, 2, and 4 months as well as 3.4, 3.8, 4.8, and 5.8 years after
the onset of symptoms. The institutional review board
approved the study and the parents gave informed consent
before each examination. The first three studies were
conducted at 2 T (Magnetom Vision; Siemens Medical
Solutions, Erlangen, Germany), the latter four at 3 T
(Magnetom Trio). Proton MR spectra (64 accumulations)
were acquired with use of a STEAM localization sequence
with repetition time (TR)/echo time (TE)/mixing time (TM)=
6000/20/10 ms as described [18, 19]. The 4.85 ml (2 T) and
4.1 ml (3 T) volume-of-interest (VOI) was placed within the
LPO WM covering the structural lesion but excluding the
perifocal edema if possible (indicated in Fig. 1b). For the last
MRS examination the VOI was reduced to 2.7 ml to account
for tissue loss. Absolute concentrations of N-acetylaspartate
and N-acetylaspartylglutamate (tNAA), creatine and phos-
phocreatine (tCr), choline-containing compounds (Cho),
myo-inositol (Ins), and lactate (Lac) were determined by
LCModel fitting a linear combination of model spectra [20]
and compared to age-matched controls (n=14) taken from
Pouwels et al. [21].
Diffusion tensor imaging
DTI was performed on axial slices of 6 mm thickness at 2 T
and 4 mm at 3 T using a diffusion-weighted partial Fourier
single-shot STEAM MRI sequence with TR=6.7 s, TE=
74 ms (2 T) and TR=16.2 s, TE=50 ms (3 T), and readout
flip angle 10° [22, 23]. The protocol comprised a reference
image without diffusion-weighting and diffusion-weighted
images at a b value of 1000 s mm
−2 along 24 directions of
alternate polarity (icosahedron scheme). Maps of the
fractional anisotropy (FA) and mean diffusivity (MD) were
calculated from the estimated diffusion tensor and co-
registered to anatomical images using FSL 3.2 (FMRIB
Software Library,Oxford,U.K.). Regionalmean FAand MD
values were determined for the same LPO WM lesion as
studied by proton MRS (indicated in Fig. 2a). These values
were compared to data from age- and gender-matched
controls (seven healthy female subjects, age range 13–
20 years, mean±standard deviation (SD) 16.2±2.9 years).
To allow for adequate fiber tractography, DTI in the 6th
examination was performed at 2.2 mm isotropic resolution
(38 contiguous slices, 3 averages). Estimates of axonal
projections were computed by the fiber assignment by
continuous tracking (FACT) algorithm using software
developed in-house [24, 25]. Tracking terminated when
the FA value was lower than 0.15 or the main diffusion
directions in consecutive steps differed by more than 40°
(empirically optimized thresholds). The geniculo-calcarine
tracts were determined by region-to-region tracking using
regions-of-interest (ROIs) defined on color-coded maps of
the main diffusion direction. In order to study secondary
degenerative effects of the corpus callosum (CC), the
surface of the CC was reconstructed. To compare CC
abnormalities of the patient with an age-matched control, a
recently developed CC scheme was applied to delineate the
fiber topography of the CC by separating transcallosal
projections into prefrontal, premotor (and supplementary
motor), primary motor, primary sensory, parietal, temporal,
and occipital regions [26].
Results
Figure 3 illustrates the time course of metabolic disturbances
depicted during follow-up proton MRS of the large LPO
WM lesion. Table 1 summarizes corresponding absolute
metabolite concentrations in comparison to age-matched
controls [21]. The serial metabolite patterns indicated a
triphasic development comprising an acute phase 1 month
after the onset of symptoms, an intermediate phase extending
for at least 3 months, and a chronic phase covering the entire
observation period of almost 6 years.
The acute phase was characterized by a reduction of
most metabolite concentrations in conjunction with a
pronounced elevation of Lac. In more detail, the tNAA
concentration was significantly reduced yielding only 22%
of control values. In the intermediate phase, the tNAA level
Neuroradiology (2009) 51:113–121 115partially recovered and after another 3 to 4 years reached a
constant level of about 70% of control values. The
concentration of tCr was acutely decreased to 77% of
control values but regained normal levels within 3 months.
The Cho concentration was elevated up to 188% of control
values in the acute and intermediate phase, but gradually
declined to normal concentrations after 3 to 4 years. The
reduced Ins concentration in the acute phase (64% of control
values) was followed by a rapid increase to 174 and 205% of
control values in the intermediate phase. This high Ins level
was maintained for up to 4 years before slowly decreasing
toward normal values (136% at 5.8 years). The acutely
elevated Lac concentration of 8 mmol/l (control<1 mmol/l)
decreased to 4.1 mmol/l during the intermediate phase and
subsequently over more than 4 years to below detectability.
DTI resulted in reduced anisotropy measures and
increased water diffusivities. Figure 2 displays an overlay
of FA maps onto T1-weighted images that reveal the loss of
anisotropy within the LPO WM region as compared to the
contralateral hemisphere. The lesion had its largest extension
1 month after the onset of symptoms (Fig. 2a) and appeared
diminished in size already one month later (Fig. 2b). On all
subsequent measurements, no further changes could be
detected leaving a pronounced lack of anisotropy in the
affected area (Fig. 2c–f). Quantitative analyses in Table 2
showed very low FAvalues of about 0.11 (on a scale from 0
to 1.0) consistent with (almost) isotropic conditions that
persisted throughout the entire observation period. The
corresponding MD values were significantly elevated in the
acute phase (145% of normal controls) and further
Fig. 2 Thresholded axial fractional anisotropy maps overlaid onto
corresponding T1-weighted images at a 1 month, b 2 months,
c 4 months, d 3.4 years, e 4.8 years, and f 5.8 years after the onset
of symptoms. The ellipse shown in a indicates the location for ROI-
analysis of FA and MD values
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the chronic phase.
The FA maps expose a thinning of the inferior fronto-
occipital fasciculus and the inferior longitudinal fasciculus
as compared to the contralateral side. Fiber tractography
revealed a thinning of the ipsilateral geniculo-calcarine
tract. As demonstrated in Fig. 4 using three-dimensional
views of fiber reconstructions relative to T1-weighted MRI
anatomy, tracking of the optic radiation discontinued
abruptly at the anterior border of the lesion.
In comparison to an age-matched control, the CC in Fig. 5
showed a decrease of the CC volume as constituted by all
transcallosal fibers projecting into defined cortical areas
(Fig. 5a). The thinning was accompanied by a reduced
anisotropy and turned out to be most pronounced in the
premotor and supplementary motor area and to a lesser
extent in the primary motor cortex (Fig. 5b) which
correspond—according to the topographic scheme suggested
by Hofer and Frahm [26]—to regions II and III, respectively.
Discussion
The combined neurochemical and microstructural altera-
tions observed here for a typical BC lesion in vivo are in
close agreement with previous findings from histopatho-
logical assessments [3–7]. The temporal evolution of the
metabolic disturbances is indicative of initial neuroaxonal
damage and active demyelination which are followed by
partial recovery and gliotic processes. The persistently
Fig. 3 Serial proton MRS of the left parieto-occipital lesion shown in Fig. 1 at a 1 month, b 2 months, c 4 months, d 3.4 years, e 4.8 years, and f
5.8 years after the onset of symptoms
Table 1 Absolute metabolite concentrations in the left parieto-occipital white matter lesion.
Time after onset (age) 1 mo (13.8) 2 mos (13.9) 4 mos (14.1) 3.4 yrs (17.1) 3.8 yrs (17.4) 4.8 yrs (18.4) 5.8 yrs (19.4) Controls
tNAA 1.7
a 2.8
a 3.8
a 5.0
a 5.2
a 5.6
a 5.4
a 7.9±0.5
tCr 3.6
a 4.1 5.4 4.9 5.0 5.2 4.1 4.7±0.5
Cho 2.3
a 3.0
a 2.5
a 2.2
a 1.7 1.6 1.4 1.6±0.2
Ins 2.5 6.8
a 8.0
a 8.0
a 6.4
a 6.1
a 5.3 3.9±1.1
Lac 8.0 4.1 4.1 1.5 1.4 <1 <1 <1
Values are given in mmol/l as a function of time after onset of symptoms (yrs years, mo month, mos months) as well as the age (in years) and
compared to age-matched controls (mean±SD, n=14, age 15.9±3.5 yrs) taken from Pouwels et al. [21].
aValues differ from controls by ≥2 SD.
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reflect a permanent damage to the tissue structure. These
latter findings refer to the neuroaxonal connectivity in both
the lesioned area disrupting the optic radiation unilaterally
and the premotor and motor regions of the corpus callosum.
Active demyelination and gliosis
The initial metabolite pattern of the LPO WM lesion with
strikinglyreducedtNAAandhighChoandLacconcentrations
isinlinewithactivedemyelination.Almostidenticalmetabolic
disturbances have frequently been reported for demyelinating
processes in conjunction with various leukodystrophies, for
example in children with adrenoleukodystrophy [27]. In this
context, the tNAA reduction may be taken as a sign of
neuroaxonaldamage.ThisisbecausetNAAhasbeenshownto
be predominantly localized within neurons and axons and
validated as an axon-specific marker of cerebral WM [28–30].
Complementary, the MRS-detectable Cho resonance com-
prises precursor molecules for membrane synthesis as well as
thecorrespondingdegradationproductsandthereforerelatesto
structural integrity [31]. The initial high and for almost 3 years
elevated Cho concentration may be attributed to ongoing
active demyelination and breakdown of myelin phospholipids.
However, increased membrane turnover has also been associ-
ated with inflammatory cellular infiltration which is known to
occur in BC and therefore a likely contributor to a high Cho
level [7, 32]. The subsequent gradual decrease of Cho
probably reflects the cessation of active demyelinating
processes which are usually replaced by reactive astrocytosis
and gliosis. In fact, the course of the Ins concentration, which
has been found in high concentrations in astrocytes [33], is in
excellent agreement with this histopathological observation.
The Lac concentration was strongly increased 1 month
after disease onset and slowly disappeared over time. In
general, this finding may indicate non-oxidative glycolysis
during ischemia/hypoxia or disturbances in the respiratory
chain. Although active BC lesions resemble aspects found
in early hypoxic/ischemic WM as well as in active pattern
III MS lesions [7], these are not satisfactory explanations for
our patient. Instead, Lac production may be preferentially due to
the activation of macrophages and their non-oxidative glucose
utilization, which have been found in abundance in BC lesions
[6, 34]. The observation of mobile lipids in lesions of adult
patients with BC [8, 10] could not be confirmed in our study
of a child despite the use of short-echo time proton MRS.
Table 2 Fractional anisotropy and mean diffusivity in the left parieto-occipital white matter lesion.
Time after onset (age) 1 mo (13.8) 2 mos (13.9) 4 mos (14.1) 3.4 yrs (17.1) 3.8 yrs (17.4) 4.8 yrs (18.4) 5.8 yrs (19.4) Controls
FA 0.11
a 0.18
a 0.14
a 0.12
a 0.11
a 0.07
a 0.08
a 0.44±0.08
MD 1.1
a 1.06
a 1.29
a 1.68
a 1.58
a 1.69
a 1.74
a 0.76±0.05
Fractional anisotropies (FA) and mean diffusivities (MD, in 10
−9 m
2 s
−1) are given as a function of time after onset of symptoms (yrs years, mo
month, mos months) as well as the age (in years) and compared to age-matched controls (mean±SD; n=7).
aValues differ from controls by ≥2 SD.
Fig. 4 Fiber tractography of the
patient’s geniculo-calcarine tract
4.8 years after onset of symp-
toms in three-dimensional views
of fiber reconstructions relative
to T1-weighted MRI anatomy:
a top view and b,c oblique
views of the left and right
hemisphere, respectively. Colors
correspond to the local mean
diffusion direction: red left–
right, green anterior–posterior,
and blue superior–inferior
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A most remarkable finding of this study is the substantial
recovery of tNAA during disease progression. The synthesis
of NAA from L-aspartate and acetyl-CoA catalyzed by
N-acetyl-transferase takes place inthe neuronalmitochondria.
A translocase transports it into the cytosolic compartment
from where it travels the axons via active axonal transport. As
NAA cannot be hydrolyzed in these cells, the molecule
participates in an intercompartmental cycle between neurons
and oligodendrocytes where it is catabolized by aspartoacy-
lase. It has been postulated that NAA turnover is conducted
via molecular water pumps and that it plays a major role in
brain osmoregulation [35]. Furthermore, NAA has been
suggested to act as a precursor for the neurotransmitter
NAAG, as an acetyl donor during myelination, and as a
molecule participating in interneuronal and intercellular
signaling [35, 36].
According to the aforementioned functions, several
factors may contribute to the reversible reduction of tNAA.
Firstly, edema, as a prominent feature of the acute lesion,
may simply reduce the relative number of axons per VOI
and later reverse the effect upon absorption [32]. Secondly,
owing to the osmoregulatory role of NAA, the dramatic
changes in extracellular water content during the formation
and resolution of the edema could directly affect the
intracellular NAA concentration. In fact, in animal models
without loss of neuron viability, NAA was greatly reduced
or even absent presumably solely because of its function as
a neuronal osmolyte [37]. Thirdly, the mitochondrial
function may be reversibly impaired during inflammation
in which case NAA synthesis is resumed to a significant
extent at later stages [36]. Fourthly, it could be speculated
that the axonal transport is re-established after subsidence
of active demyelination in parallel to remyelination. The
persisting reduction of tNAA to about 70% of control
values can very well be attributed to the residual atrophy,
that is permanent neuroaxonal loss, within the LPO WM.
This explanation is not only appreciable on MRI but also
supported by the structural deficits revealed by DTI.
White matter fiber structure
WM diffusion anisotropy reflects the integrity of both
axonal membranes and myelin sheaths. FA and MD values
in our patient were significantly altered in the BC lesion
and in contrast to the MRS results showed no recovery.
Reduced anisotropy and increased diffusivity point to a
structural damage within the delicate microarchitecture of
axonal membranes, periaxonal spaces, and myelin layers
which apparently remained without repair. These results are
in line with data from MS patients where a range of studies
document similar changes in response to a structural tissue
damage, for example see Rovaris et al. [38]. Two DTI
studies of adult BC reported initially reduced rather than
enhanced water diffusivity in active lesions [15, 39]. The
fact that we did not see such effects one month after disease
onset may be due to their use of very early time points as
close as day one of the disease. Almost immediate
reductions of the apparent diffusion coefficient that several
days later are followed by a reversal to higher values than
normal are a typical observation in ischemic brain tissue
after acute stroke [40].
Fiber tractography has so far not been performed in BC.
It revealed a significantly impaired optic radiation in the left
hemisphere almost 5 years after disease onset. The abrupt
fiber truncation at the anterior border of the lesion is in full
accordance with the persisting clinical symptom of right
homonym hemianopsia. Neuroaxonal damage together with
gliotic changes may be responsible not only for the lack of
Fig. 5 a,c Sagittal view of CC
surface reconstructions (yellow)
and b,d corresponding
fractional anisotropy maps of
the patient (a,b) and an age-
matched control (c,d). The
topographic scheme of the CC
[26] identifies regions with
fibers projecting into specific
cortical areas: I prefrontal lobe,
II premotor and supplementary
motor cortex, III motor cortex,
IV sensory cortex, V parietal,
temporal, and occipital lobes
Neuroradiology (2009) 51:113–121 119structural integrity and, hence, diffusion anisotropy, but
also for impairing normal axonal transport and function.
Furthermore, a surface reconstruction of the CC showed a
pronounced thinning of fiber regions interconnecting right-
and left-hemispheric premotor and supplementary motor
areas as well as primary motor cortices [26]. In a previous
study, Sydykova et al. reported a correlation between
reduced FA values in the CC and a decline in fiber integrity
and neurodegeneration in corresponding cortical areas [41].
Therefore, reduced FA values in CC regions covering fibers
of cortical premotor and supplementary motor areas
(compare Fig. 5b) fit well to the observed premotor lesions
in both hemispheres.
Concluding remarks
Serial proton MRS and DTI of a child with BC revealed a
coherentpatternofneurochemicalandstructuralabnormalities
and respective changes during disease progression. Metabolic
disturbances were consistent with acute demyelination fol-
lowed by gliosis and partial recovery of neuroaxonal
metabolite concentrations. DTI resulted in persistent alter-
ations of the microstructure not only in the MRI-detectable
lesion but also in specific regions of the CC associated with
motor functions.
In conclusion, proton MRS and DTI sensitively depict
different processes during the evolution of a BC lesion.
Whereas MRS monitors respective metabolic disturbances,
DTI-based structural alterations seem to correlate better
with the clinical symptoms. The combination of both
methods in a clinical setting allows for a more detailed
analysis of lesion development and may contribute to the
establishment of prognostic criteria.
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